Prostate stimulator for Erectile Dysfunction

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stanford Healthcare, Stanford Hospital, Stanford, CA
Erectile Dysfunction+3 More
Prostate stimulator - Device
Eligibility
18+
Male
What conditions do you have?
Select

Study Summary

The purpose of this study is to use a device to stimulate the prostate with a goal of helping improve symptoms in men with sexual dysfunction.

Eligible Conditions

  • Erectile Dysfunction
  • Sexual Dysfunctions
  • Delayed Ejaculation
  • Anorgasmia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: baseline and up to 1 month post-baseline

Month 1
change in modified International Index of Erectile Dysfunction score

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Prostate stimulation device arm
1 of 1
Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Prostate stimulator · No Placebo Group · N/A

Prostate stimulation device arm
Device
Experimental Group · 1 Intervention: Prostate stimulator · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and up to 1 month post-baseline
Closest Location: Stanford Healthcare, Stanford Hospital · Stanford, CA
Photo of california 1Photo of california 2Photo of california 3
N/AFirst Recorded Clinical Trial
2 TrialsResearching Erectile Dysfunction
0 CompletedClinical Trials

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,130 Previous Clinical Trials
35,668,895 Total Patients Enrolled
2 Trials studying Erectile Dysfunction
19 Patients Enrolled for Erectile Dysfunction
Michael Eisenberg, M.D.Principal InvestigatorStanford University

Eligibility Criteria

Age 18+ · Male Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.